AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:17AM EDT. Market open.
| Previous close | 70.85 |
| Open | 71.41 |
| Bid | 70.86 x 300 |
| Ask | 70.98 x 900 |
| Day's range | 70.86 - 71.47 |
| 52-week range | 60.47 - 75.75 |
| Volume | |
| Avg. volume | 6,186,954 |
| Market cap | 219.868B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 37.13 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.45 (2.05%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | N/A |
- Zacks
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Sales of AstraZeneca's (AZN) key drugs like Imfinzi and Farxiga are expected to have been boosted by approvals in new indications.
- Simply Wall St.
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Key Insights Given the large stake in the stock by institutions, AstraZeneca's stock price might be vulnerable to their...
- Zacks
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Astrazeneca (AZN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
© 2024 Yahoo. All rights reserved.